Treatment of Posthemorrhagic Hydrocephalus

Susan Cohen1, John Flibotte2

  • 1Department of Pediatrics, Division of Neonatology, Medical College of Wisconsin, 999 North 92nd Street, CCC 410, Milwaukee, WI 53226, USA.

Clinics in Perinatology
|February 25, 2022
PubMed

Insights

Posthemorrhagic hydrocephalus, a complication of intraventricular hemorrhage in preterm infants, requires careful management. This review examines current controversies and recent trial data on interventions for this condition.

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Critical Care Medicine

Background:

  • Intraventricular hemorrhage (IVH) affects 15-20% of preterm infants (<1500g).
  • Posthemorrhagic ventricular dilation (PHVD) is a severe complication of IVH.
  • Progressive PHVD necessitates intervention in up to 20% of severe IVH cases to prevent brain damage.

Purpose of the Study:

  • To review controversies surrounding interventions for posthemorrhagic hydrocephalus (PHVD).
  • To guide interpretation of recent trial data regarding PHVD management.
  • To discuss the implications for clinical practice and potential for more aggressive interventions.

Main Methods:

  • Literature review of recent clinical trials and expert opinions.
  • Analysis of data concerning the efficacy and timing of PHVD interventions.
  • Discussion of current guidelines and emerging treatment strategies.

Main Results:

  • Recent trials present complex data on PHVD interventions.
  • Interpretation of trial outcomes is debated, with some advocating for earlier or more aggressive approaches.
  • No universal consensus exists on the optimal management strategy for PHVD.

Conclusions:

  • Management of PHVD remains a significant clinical challenge.
  • Careful consideration of individual patient factors and evolving evidence is crucial.
  • Further research is needed to establish definitive treatment protocols for PHVD in preterm infants.